Technical Analysis for TTOO - T2 Biosystems, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | -5.76% | |
| Narrow Range Bar | Range Contraction | -5.76% | |
| Inside Day | Range Contraction | -5.76% | |
| Wide Bands | Range Expansion | -5.76% | |
| Oversold Stochastic | Weakness | -5.76% | |
| New 52 Week Closing Low | Bearish | -9.90% | |
| Wide Bands | Range Expansion | -9.90% | |
| Oversold Stochastic | Weakness | -9.90% | |
| Narrow Range Bar | Range Contraction | -14.67% | |
| Wide Bands | Range Expansion | -14.67% |
| Alert | Time |
|---|---|
| 2x Volume Pace | about 4 hours ago |
| 1.5x Volume Pace | about 4 hours ago |
| Up 3% | about 4 hours ago |
| Up 2% | about 4 hours ago |
| Up 1% | about 4 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 11/14/2024
T2 Biosystems, Inc. Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products based on its proprietary platform. Its T2 Magnetic Resonance platform enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company offers T2Dx, a bench-top instrument, which has completed a pivotal clinical trial for performing diagnostic tests in sepsis and other applications; and T2Stat, an integrated instrument for hemostasis applications. It is also developing T2Candida panel that has completed a pivotal clinical trial for identifying pathogens associated with sepsis; T2HemoStat panel, which includes a set of hemostasis measurements, including platelet function, clotting time, and clot degradation; and T2Bacteria, a multiplex diagnostic panel that detects the bacterial pathogens associated with sepsis. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cell Biology Biomarkers Diagnostic Products In Vitro Diagnostic Tests Magnetic Resonance Blood Plasma Blood Coagulation Intensive Care Medicine In Vitro Diagnostics Pivotal Coagulation System Hemostasis Platelet Sepsis Whole Blood
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.3799 |
| 52 Week Low | 0.4417 |
| Average Volume | 594,563 |
| 200-Day Moving Average | 3.57 |
| 50-Day Moving Average | 1.39 |
| 20-Day Moving Average | 0.74 |
| 10-Day Moving Average | 0.54 |
| Average True Range | 0.11 |
| RSI (14) | 15.97 |
| ADX | 49.43 |
| +DI | 10.77 |
| -DI | 41.85 |
| Chandelier Exit (Long, 3 ATRs) | 1.54 |
| Chandelier Exit (Short, 3 ATRs) | 0.76 |
| Upper Bollinger Bands | 1.20 |
| Lower Bollinger Band | 0.28 |
| Percent B (%b) | 0.2 |
| BandWidth | 124.60 |
| MACD Line | -0.29 |
| MACD Signal Line | -0.31 |
| MACD Histogram | 0.0221 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.52 | ||||
| Resistance 3 (R3) | 0.53 | 0.51 | 0.51 | ||
| Resistance 2 (R2) | 0.51 | 0.50 | 0.51 | 0.51 | |
| Resistance 1 (R1) | 0.49 | 0.49 | 0.48 | 0.48 | 0.51 |
| Pivot Point | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
| Support 1 (S1) | 0.45 | 0.46 | 0.44 | 0.44 | 0.42 |
| Support 2 (S2) | 0.43 | 0.45 | 0.43 | 0.42 | |
| Support 3 (S3) | 0.41 | 0.43 | 0.41 | ||
| Support 4 (S4) | 0.40 |
